Precision medicine for high-risk gene fusions in pediatric AML: a focus on KMT2A, NUP98, and GLIS2 rearrangements. Egan G, Tasian SK. Blood 2025;145:2574-2586.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Egan G, Tasian SK. Precision medicine for high-risk gene fusions in pediatric AML: a focus on KMT2A, NUP98, and GLIS2 rearrangements. Blood 2025;145:2574-2586.
PMID: 39808803